EVEROLIMUS Test Cost AED:1020.0 Symptoms Diagnosis
Test Name: EVEROLIMUS Test
Components: Price 1020.0 AED
Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).
Report Delivery: Sample Daily by 5 pm; Report Same day
Method: LC-MS/MS
Test type: Therapeutic Drug Monitoring, Transplantation
Doctor: Transplant Surgeon, Nephrologist
Test Department: GENETIC
Pre Test Information: Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).
Test Details: Everolimus is a medication that belongs to a class of drugs called mTOR inhibitors. It is used to treat various types of cancer, including advanced breast cancer, advanced kidney cancer, neuroendocrine tumors, and certain types of brain tumors. The drug works by inhibiting the activity of a protein called mTOR (mammalian target of rapamycin), which plays a role in the growth and division of cells. By blocking mTOR, everolimus helps to slow down or stop the growth of cancer cells. Everolimus is typically taken orally in the form of tablets or liquid. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as other individual factors. Common side effects of everolimus may include mouth sores, diarrhea, nausea, fatigue, and rash. Before starting treatment with everolimus, it is important to discuss any existing medical conditions, medications, or allergies with a healthcare provider. They will also monitor the patient’s blood counts and liver function regularly during treatment. Overall, everolimus is an important treatment option for certain types of cancer and can help improve outcomes and quality of life for patients. However, like any medication, it may have side effects and risks, so it should only be used under the guidance of a healthcare professional.
Test Name | EVEROLIMUS Test |
---|---|
Components | |
Price | 1020.0 AED |
Sample Condition | 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough). |
Report Delivery | Sample Daily by 5 pm; Report Same day |
Method | LC-MS/MS |
Test type | Therapeutic Drug Monitoring, Transplantation |
Doctor | Transplant Surgeon, Nephrologist |
Test Department: | GENETIC |
Pre Test Information | Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough). |
Test Details |
Everolimus is a medication that belongs to a class of drugs called mTOR inhibitors. It is used to treat various types of cancer, including advanced breast cancer, advanced kidney cancer, neuroendocrine tumors, and certain types of brain tumors. The drug works by inhibiting the activity of a protein called mTOR (mammalian target of rapamycin), which plays a role in the growth and division of cells. By blocking mTOR, everolimus helps to slow down or stop the growth of cancer cells. Everolimus is typically taken orally in the form of tablets or liquid. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as other individual factors. Common side effects of everolimus may include mouth sores, diarrhea, nausea, fatigue, and rash. Before starting treatment with everolimus, it is important to discuss any existing medical conditions, medications, or allergies with a healthcare provider. They will also monitor the patient’s blood counts and liver function regularly during treatment. Overall, everolimus is an important treatment option for certain types of cancer and can help improve outcomes and quality of life for patients. However, like any medication, it may have side effects and risks, so it should only be used under the guidance of a healthcare professional. |